Retrospective Data Analysis of CKRT Treatments in Adult Mode With multiFiltratePRO
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 80
- 试验地点
- 3
- 主要终点
- Analysis of treatments with multiFiltratePRO
研究概览
简要总结
The multiFiltratePRO is a device for extracorporeal blood purification treatments.
In this retrospective analysis, the treatments of patients who received at least one treatment with the investigational device as mentioned between January 2015 and January 2024 will be documented in a chronological order. No further control treatments will be investigated in this one-arm design. The design is considered to be appropriate to reflect daily clinical practice and to contribute to empirical evidence of performance of the multiFiltratePRO system.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with an indication for the extracorporeal blood treatment suffering from AKI who received CKRT adult mode treatment for at least once with: Heparin-Continuous veno-venous hemofiltration Hep-CVVH (Pre CVVH, Post CVVH and Pre-Post CVVH), Heparin-Continuous veno-venous hemodialysis Hep-CVVHD, Heparin-Continuous veno-venous hemodiafiltration Hep-CVVHDF (Pre-CVVHDF and Post-CVVHDF), Citrate-Calcium(Ci-Ca)-CVVHD, Citrate-Calcium(Ci-Ca) CVVHDF, between January 2015 and January 2024, with the investigational device, have to be included in the study in chronological order.
- •No age restriction for heparin modes
- •Age ≥ 18 years for Ci-Ca modes at treatment start
- •Patient´s body weight ≥ 40kg irrespective of age
- •Acute Kidney Injury (AKI) OR chronic dialysis patients with clinical indication for CKRT
排除标准
- •Participation in an interventional clinical study during the retrospectively collected CKRT treatment data
- •Previous participation in the same study
- •No study-specific exclusion criteria based on contraindications due to the retrospective character of the study
结局指标
主要结局
Analysis of treatments with multiFiltratePRO
时间窗: documentation of max.7 treatment days
Performance data of defined multiFiltratePRO CKRT treatments in adult mode with regard to fluid balance (effluent dose) are analysed
次要结局
未报告次要终点